The purpose of this memorandum is to provide guidance on the vendor-related WIC provision reflected in PL 109-97, which provides WIC funding for FY 2006.
This policy memorandum clarifies and updates current policy on price adjustments, vendor, participant, and local agency collections, fines, civil money penalties, and program income to reflect amendments to WIC program legislation and regulations since the issuance of WIC Policy Memorandum #96-3.
This memorandum provides guidance on the implementation of the nondiscretionary infant formula cost containment provisions of PL 108-265, the Child Nutrition and WIC Reauthorization Act of 2004.
Authorized by the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (MMA), the prescription drug discount card provides Medicare beneficiaries with negotiated prices that should be lower than the regular price of prescription drugs.
This policy memorandum provides guidance to state and local agencies on the WIC Racial/Ethnic Data Collection.
This memorandum provides guidance concerning allowable FMNP costs that may be covered with federal WIC funds. It is intended to promote accuracy and uniformity in the application of allowable cost principles to decisions about FMNP related costs, as state agencies seek to maximize federal funding.